ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 0610 • ACR Convergence 2022

    Patient-derived Organoids Reveal Transcriptional Regulation of Synovial Lining Fibroblast Differentiation

    Sonia Presti1, Gerald FM Watts1, Zhu Zhu1, Kartik Bhamidipati1, Junning Case1, Yuhong Li1, Teri Bowman1, Suppawat Kongthong1, ilya Korsunsky1, Michael Brenner2 and Kevin Wei3, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Synovial lining fibroblasts secrete factors into the joint cavity that promote joint lubrication1. In inflammatory arthritis, sublining fibroblasts undergo marked expansion while lining fibroblasts…
  • Abstract Number: 1149 • ACR Convergence 2022

    A Novel Mitochondrial Variant as a Predictor for the Rapid Progressive Knee Osteoarthritis Phenotype: Development of a Predictive Model and Functional Studies

    Alejandro Durán-Sotuela1, Mercedes Fernández-Moreno1, Tamara Hermida-Gómez1, Sara Relaño1, Victoria Suárez-Ulloa2, vanesa Balboa-Barreiro3, Natividad Oreiro1, Jorge Vázquez-García1, FJ Blanco1 and Ignacio Rego-Pérez1, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2Plataforma de Bioinformática. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 3Unidad de apoyo a la Investigación. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

    Background/Purpose: Knee osteoarthritis progression is heterogeneous in the population, being the most aggresive form the rapid progressive knee osteoarthritis (RPKOA). These patients suffer a worsening…
  • Abstract Number: 1755 • ACR Convergence 2022

    Improving Quality of Life Through Connection: A Scoping Review of Peer Coaching Interventions in the Field of Rheumatology

    Megan Creasman1, Mackenzie Brown2, Yuliana Domínguez Páez3, Michelle Demetres4, Monika Safford4 and Iris Navarro-Millan4, 1NYP-Weill Cornell, New York, NY, 2Weill Cornell Medicine, Brooklyn, NY, 3Weill Cornell Medicine, Bronx, NY, 4Weill Cornell Medicine, New York, NY

    Background/Purpose: Peer coaches are lay individuals providing health education and behavior change interventions, and often have the same condition as the person that they are…
  • Abstract Number: 1897 • ACR Convergence 2022

    A Preliminary Estimate of Objectively Measured Sedentary Behavior in Knee Osteoarthritis

    Thomas Bye, Dana Voinier, Jason Jakiela, Jéssica Bianca Aily and Daniel White, University of Delaware, Newark, DE

    Background/Purpose: Adults with knee osteoarthritis (OA) are thought to have elevated levels of sedentary behavior (SB). The Sedentary Behavior Research Network defines SB as total…
  • Abstract Number: 1913 • ACR Convergence 2022

    The Association of Radiographic Chondrocalcinosis with Localized Structural Outcomes in Knee OA: The Multicenter Osteoarthritis Study

    Jean Liew1, Ali Guermazi2, Mohamed Jarraya3, Na Wang1, David Felson2, Cora E. Lewis4, Michael Nevitt5, James Torner6, John A. Lynch7 and Tuhina Neogi1, 1Boston University School of Medicine, Boston, MA, 2Boston University, Boston, MA, 3Massachusetts General Hospital, Boston, MA, 4University of Alabama at Birmingham, Birmingham, AL, 5University of California at San Francisco, Orinda, CA, 6University of Iowa, Iowa City, IA, 7UCSF, San Francisco, CA

    Background/Purpose: Intra-articular (IA) mineralization due to calcium crystal deposition may contribute to OA pathology through inflammation, release of pro-catabolic factors, or altered cartilage biomechanical properties.…
  • Abstract Number: PP09 • ACR Convergence 2022

    A Matter of Life and Death: Why Diversity, Equity and Inclusion Matter for Health Care Providers

    Tonya Horton, Rutgers University, Cherry Hill, NJ

    Background/Purpose: In 2017, I went from exercising daily to hardly able to walk due to severe knee pain. My primary care doctor ordered x-rays and…
  • Abstract Number: 0029 • ACR Convergence 2022

    Characterizing the Anti-fibrotic Effect of Tofacitinib in TGF-β Stimulated Fibroblast-like Synoviocytes from Patients with OA

    Sofie Falkenløve Madsen1, Sarah Madsen2, Elle Hollaar3, Thorbjørn Gantzel4, Anne-Christine Bay-Jensen3 and Christian Thudium3, 1University of Copenhagen / Nordic Bioscience, Herlev, Denmark, 2Nordic Bioscience, University of Copenhagen, Herlev, Denmark, 3Nordic Bioscience, Herlev, Denmark, 4Gentofte Hospital, Gentofte, Denmark

    Background/Purpose: Many osteoarthritis (OA) patients develop fibrosis of the synovial membrane leading to joint swelling, stiffness, and pain. Synovial fibroblasts activated in the synovial membrane…
  • Abstract Number: 0706 • ACR Convergence 2022

    Association Between Metabolic Syndrome and Knee Pain over 10-13 Years in Middle-Aged Adults

    Ambrish Singh, Brooklyn Fraser, Alison Venn, Leigh Blizzard, Changhai Ding and Benny Samuel Antony, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

    Background/Purpose: Metabolic syndrome (MetS) is characterised by the clustering of central obesity with metabolic abnormalities. MetS has been suggested as having a role in osteoarthritis…
  • Abstract Number: 1152 • ACR Convergence 2022

    A Novel Serological Biomarker Measuring a Fragment of Cartilage Intermediate Layer Protein 1 Is Highly Upregulated in Rheumatic Diseases

    Helena Port1, Walter P Maksymowych2, Morten Karsdal3, Anne-Christine Bay-Jensen3 and Signe Holm Nielsen3, 1University of Copenhagen, Copenhagen, Denmark, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3Nordic Bioscience, Herlev, Denmark

    Background/Purpose: A hallmark of rheumatic joint diseases is altered cartilage protein turnover and protein composition. During cartilage erosions, the cartilage intermediate layer protein-1 (CILP-1), is…
  • Abstract Number: 1759 • ACR Convergence 2022

    Factors Affecting Success of Behavioral Interventions to Improve Physical Activity in Patients with Knee Osteoarthritis

    Lakshmi Jayaram1, jing song2, Pamela Semanik3, Daniel Pinto4, Linda Ehrlich-Jones5, Lutfiyya Muhammad6, Alison Chang6 and Rowland Chang7, 1McGaw Medical Center, Northwestern University, Chicago, IL, 2Northwestern University, Chicago, IL, 3Rush University, Chicago, IL, 4Marquette University, Wauwatosa, WI, 5Shirley Ryan AbilityLab, Aurora, IL, 6Northwestern University Feinberg School of Medicine, Chicago, IL, 7Northwestern University Division of Rheumatology, Chicago, IL

    Background/Purpose: Knee osteoarthritis (KOA) is a chronic long-term condition that results in pain, disability and reduced quality of life. Over 13 million US adults 45…
  • Abstract Number: 1898 • ACR Convergence 2022

    Radiographic Osteoarthritis Progression Can Be Predicted via Pyrosequencing Analysis of Baseline Peripheral Blood

    Chris Dunn1, Cassandra Velasco2, Leoni Schlupp3, Emmaline Prinz3, Vladislav Izda4, Liubov Arbeeva5, Yvonne Golightly6, Amanda Nelson6 and Matlock Jeffries3, 1University of Oklahoma Health Sciences Center, Edmond, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oklahoma Medical Research Foundation, New York, NY, 5University of North Carolina Chapel Hill, Chapel Hill, NC, 6UNC School of Medicine, Chapel Hill, NC

    Background/Purpose: Knee osteoarthritis (OA) is a heterogeneous disease characterized by a variety of clinical and molecular phenotypes. However, we do not yet have robust biomarkers…
  • Abstract Number: 1914 • ACR Convergence 2022

    Acoustic Classification of Early and Advanced Osteoarthritis of the Knee in Clinical Settings

    Dave Ewart1, Ashley Draisey2, Omer Inan3, Chris Nichols3 and Goktug Ozmen3, 1Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, 2Allina Health, Minneapolis, MN, 3Georgia Institute of Technology, Atlanta, GA

    Background/Purpose: Knee osteoarthritis (OA) is a prevalent and debilitating disease. Diagnosis of early knee OA is difficult and insensitive with current technologies. The human knee…
  • Abstract Number: 0030 • ACR Convergence 2022

    Fluidic Shear Stress Reduces TNFα-mediated Cartilage Damage in a 3D Model of Degenerative Joint Disease

    Alexandra Damerau1, Duc Ha Do Nguyen1, Christina Lubahn1, Thomas Leeuw2, Timo Gaber3 and Frank Buttgereit3, 1Charité-Universitätsmedizin Berlin, Berlin, Germany, 2Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany, 3Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin / DRFZ Berlin, Berlin, Germany

    Background/Purpose: Degenerative joint diseases such as osteoarthritis (OA) ultimately result in the breakdown of cartilage. The exact underlying mechanisms of cause and progression of OA…
  • Abstract Number: 0756 • ACR Convergence 2022

    Rheumatic Toxicities of Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and the Effect of Pre-existing Autoimmune and Non-immune Mediated Rheumatic Conditions

    Alana Bruce1, Georgina V Long2, Alexander M Menzies2, Brian Fernandes3 and Fredrick Joshua4, 1Macquarie University, Balaclava, Victoria, Australia, 2Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia, 3Royal Prince Alfred Hospital, Sydney, Australia, 4Macquarie University, Integrated Specialist Medical Care, Sydney, Australia

    Background/Purpose: To estimate the frequency of rheumatic toxicities of immune checkpoint inhibitors (ICI) presenting as de novo or exacerbations of pre-existing rheumatic disease in patients…
  • Abstract Number: 1228 • ACR Convergence 2022

    Distinctive Alterations in the Functional Anatomy of the Cerebral Cortex in Pain-sensitized Osteoarthritis and Fibromyalgia Patients

    Jesús Pujol1, Fabiola Ojeda1, Laura Blanco-Hinojo1, Andrea Doreste1, Gerard Martinez-Vilavella1, Víctor Pérez-Solá1, Joan Deus2 and Jordi Monfort1, 1Hospital del Mar, Barcelona, Spain, 2Autonomous University of Barcelona, Barcelona, Spain

    Background/Purpose: Fibromyalgia is a primary pain sensitization disorder showing augmented pain sensitivity with no apparent origin. In contrast, secondary sensitization often occurs in knee osteoarthritis…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology